Johnson and Johnson

Johnson & Johnson, Eli Lilly pause covid-19 trials for possible safety ...

Washington Post - 14 Oct 2020
The trial is the second large vaccine trial to temporarily stop giving inoculations in the United States.

• More

Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know

Yahoo Finance - 05 Jun 2023
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know  ...

• More

Analysis: Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast

Reuters - 05 Jun 2023
Analysis: Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast  ...

• More

With FDA filing, Legend, J&J seek broader use of Carvykti

FiercePharma - 07 Jun 2023
With FDA filing, Legend, J&J seek broader use of Carvykti  ...

• More

J&J's multiple myeloma combo produces 96% Carvykti-like response

FierceBiotech - 05 Jun 2023
J&J's multiple myeloma combo produces 96% Carvykti-like response  ...

• More

Johnson & Johnson stock outperforms market on strong trading day

MarketWatch - 05 Jun 2023
Johnson & Johnson stock outperforms market on strong trading day  ...

• More

J&J faces new trial over talc cancer claims, amid settlement push

Reuters - 31 May 2023
J&J faces new trial over talc cancer claims, amid settlement push  ...

• More

Johnson & Johnson vaccine doses getting thrown out in the US

Business Insider - 26 May 2023
Johnson & Johnson vaccine doses getting thrown out in the US  ...

• More

J&J secures dismissal of whistleblower case over misuse of confidential info

Reuters - 02 Jun 2023
J&J secures dismissal of whistleblower case over misuse of confidential info  ...

• More

J&J Covid-19 vaccine no longer available in the US

CNN - 15 May 2023
J&J Covid-19 vaccine no longer available in the US  ...

• More

J&J's proposed talc settlement would pay $400 million to US state AGs

Reuters - 16 May 2023
J&J's proposed talc settlement would pay $400 million to US state AGs  ...

• More

Johnson & Johnson Relinquishes Top Spot To Eli Lilly (NYSE:JNJ)

Seeking Alpha - 08 Jun 2023
Johnson & Johnson Relinquishes Top Spot To Eli Lilly (NYSE:JNJ)  ...

• More

Johnson & Johnson : CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progression or Death by 74 Percent in Earlier-Line Multiple Myeloma Treatment in the Landmark Phase 3 CARTITUDE-4 Study

Marketscreener.com - 05 Jun 2023
Johnson & Johnson : CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progression or Death by 74 Percent in Earlier-Line Multiple Myeloma Treatment in the Landmark Phase 3 CARTITUDE-4 Study  ...

• More

Releases its 2022 Health for Humanity Report and We All Belong ...

Johnson & Johnson - 07 Jun 2023
Releases its 2022 Health for Humanity Report and We All Belong ...  ...

• More

Morning Medical Update: Johnson and Johnson shot no longer ...

Medical Economics - 06 Jun 2023
Morning Medical Update: Johnson and Johnson shot no longer ...  ...

• More

Johnson & Johnson Unusual Options Activity - Johnson & Johnson (NYSE:JNJ)

Benzinga - 07 Jun 2023
Johnson & Johnson Unusual Options Activity - Johnson & Johnson (NYSE:JNJ)  ...

• More

Johnson & Johnson stock rises Thursday, outperforms market

MarketWatch - 08 Jun 2023
Johnson & Johnson stock rises Thursday, outperforms market  ...

• More

CDC: Johnson & Johnson COVID-19 vaccine no longer available in ...

Spectrum News NY1 - 15 May 2023
CDC: Johnson & Johnson COVID-19 vaccine no longer available in ...  ...

• More

Talc Victims to Johnson & Johnson: There's No Escaping Science ...

Business Wire - 07 Jun 2023
Talc Victims to Johnson & Johnson: There's No Escaping Science ...  ...

• More

J&J's COVID vaccine taken by 19 MILLION Americans is pulled by ...

Daily Mail - 08 Jun 2023
J&J's COVID vaccine taken by 19 MILLION Americans is pulled by ...  ...

• More